Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

20/1/14

PUW3

Jessica Soto

Modelling taste studies

27/1/14

PUW1

Joanna

Practice for South Africa

3/2/14

PUW3

Liana

PK of tyrosine kinase inhibitors in PKD animal model

10/2/14

PUW4

Eva

Neogent predictions

17/2/14

PUW3

Deji

Hepatitis and HIV co-infection modelling

24/2/14

PUW1

 

 

3/3/14

PUW2

Rollo

Upgrade practice

10/3/14

PUW1

Joe

Clonidine PKPD for sedation in PICU

17/3/14

PUW3

Andreas

Clinical protocol development for GAbapentine in Paediatric pain Project : Optimization of the trial design characteristics based on (E)D optimality using popED.

24/3/14

PUW3

Julie

MRC Biostats talk on new methods for genetic covariates in PKPD modelling.

31/3/14

PUW1

Flora

Clinical protocol development for GAbapentine in Paediatric Pain Project : Dose rationale and dosing schedule for characterisation efficacy in chronic pain

7/4/14

PUW3

Morris

Development and dose rationale for fixed dose combinations for the treatment of tuberculosis

14/4/14

WCD

Andrezj

Population Pharmacokinetic Analysis of Efavirenz in African Children using mixture modelling to describe clearance multimodality

26/4/14

PUW4

 

 

12/5/14

PUW2

Carlos Hoyo

Nifedipine PKPD

19/5/14

WCC

Gavin Jarvis

A Modelling Approach to the Genetics of Embryonic Growth

23/6/14

PUW3

All

PAGE meeting review

30/6/14

PUW2

Flora

NLME cluster demonstration

7/7/14

PUW1

Sophie Rhodes

The immune response to BCG vaccination over time and the population variation of immune response dynamics

14/7/14

PUW2

Joanna and Jamie

An ODE model of peptide presentation by MHC-I / Geometric MCMC

 

 

 

SUMMER